Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients

NCT02416778 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Ferric carboxymaltose, Ferinject® 50mg Iron/ml Solution for Injection / Infusion

Sponsor

Georg-Christian Funk